Alzheimer's disease and anaesthesia: Potential relationships and clinical implications

被引:2
|
作者
Andre, D. [1 ]
Dartigues, J. -F. [2 ]
Sztark, F. [1 ]
机构
[1] Univ Bordeaux 2, CHU Bordeaux, Grp Hosp Pellegrin, Serv Anesthesie Reanimat 1, F-33076 Bordeaux, France
[2] Univ Bordeaux 2, INSERM, U897, F-33076 Bordeaux, France
来源
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION | 2011年 / 30卷 / 01期
关键词
Alzheimer's disease; Postoperative cognitive dysfunction; Anaesthetics neurotoxicity; POSTOPERATIVE COGNITIVE DYSFUNCTION; NITROUS OXIDE ANESTHESIA; ISOFLURANE INDUCES APOPTOSIS; INDUCED NEURONAL APOPTOSIS; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E GENOTYPE; BETA-PEPTIDE; GLUCOSE DEPRIVATION; INTRACELLULAR CA2+; GENERAL-ANESTHESIA;
D O I
10.1016/j.annfar.2010.10.013
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Alzheimer's disease is the most common form of dementia. As the aging population increases, Alzheimer's disease is becoming a major concern of Public Health. Many molecular lesions have been detected in Alzheimer's disease, but physiopathology is still poorly understood. If the neurotoxicity of anaesthetics in human remains debatable, perioperative period is certainly a high-risk factor for cognitive impairment, especially in elderly population. Large clinical studies are required to develop new strategies for perioperative management in such patients, including the adjustment of anaesthesia techniques. Before that, information of patient and its relatives and a particular attention for elderly during anaesthesia and perioperative period should be considered. (C) 2010 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 50 条
  • [31] Aβ aggregation and possible implications in Alzheimer's disease pathogenesis
    Bharadwaj, Prashant R.
    Dubey, Ashok K.
    Masters, Colin L.
    Martins, Ralph N.
    Macreadie, Ian G.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (03) : 412 - 421
  • [32] The implications of genetic studies on the pathogenesis of Alzheimer's disease
    Sasaki, H
    NEUROPATHOLOGY, 1998, 18 (01) : 103 - 110
  • [33] Microglial activation states and their implications for Alzheimer's Disease
    Valiukas, Zachary
    Tangalakis, Kathy
    Apostolopoulos, Vasso
    Feehan, Jack
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2025, 12 (01):
  • [34] Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimer's Disease
    Li, Chuanyu
    Zhao, Rui
    Gao, Kai
    Wei, Zheng
    Yin, Michael Yaoyao
    Lau, Lok Ting
    Chui, Dehua
    Yu, Albert Cheung Hoi
    CURRENT ALZHEIMER RESEARCH, 2011, 8 (01) : 67 - 80
  • [35] Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications
    Sabbagh, Jonathan J.
    Kinney, Jefferson W.
    Cummings, Jeffrey L.
    NEUROBIOLOGY OF AGING, 2013, 34 (01) : 169 - 183
  • [36] Inflammation and Alzheimer's disease: Relationships between pathogenic mechanisms and clinical expression
    Eikelenboom, P
    Rozemuller, JM
    van Muiswinkel, FL
    EXPERIMENTAL NEUROLOGY, 1998, 154 (01) : 89 - 98
  • [37] Anesthesia, surgery, illness and Alzheimer's disease
    Eckenhoff, Roderic G.
    Laudansky, Krzysztof F.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 47 : 162 - 166
  • [38] Platelet Activation in Alzheimer's Disease: From Pathophysiology to Clinical Value
    Laske, Christoph
    Sopova, Kateryna
    Stellos, Konstantinos
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (05) : 626 - 630
  • [39] A Potential Role for the Ketogenic Diet in Alzheimer's Disease Treatment: Exploring Pre-Clinical and Clinical Evidence
    Oliveira, Tadeu P. D.
    Morais, Ana L. B.
    dos Reis, Pedro L. B.
    Palotas, Andras
    Vieira, Luciene B.
    METABOLITES, 2024, 14 (01)
  • [40] Potential Applications of Artificial Intelligence in Clinical Trials for Alzheimer's Disease
    Seo, Younghoon
    Jang, Hyemin
    Lee, Hyejoo
    LIFE-BASEL, 2022, 12 (02):